Dust-Based Surveillance for Detecting Emerging Viral Outbreaks

Key Takeaways

• Dust sampling detected 54 viruses across 30 indoor sites
• Includes SARS‑CoV‑2, influenza, norovirus, Epstein‑Barr virus
• Uses PCR and novel RNA sequencing panel covering 200 pathogens
• Dust remains stable at room temperature, enabling easy collection
• Provides high‑resolution, building‑level surveillance complementing wastewater monitoring

Pulse Analysis

Environmental monitoring has long relied on wastewater to gauge community infection trends, but that method aggregates data over large catchments and often misses localized spikes. Dust, by contrast, accumulates biological material shed by occupants and integrates air, surface and human activity signatures over time. Because dust can be collected during routine cleaning, it sidesteps the need for specialized plumbing or disruptive sampling, offering a pragmatic way to monitor viral presence in schools, offices, or other indoor environments where rapid response is critical.

The Ohio State team leveraged both quantitative PCR and a cutting‑edge RNA‑sequencing technique to scan for up to 200 viral targets in a single assay. This multiplexed approach uncovered a diverse viral landscape—SARS‑CoV‑2, multiple influenza strains, norovirus, Epstein‑Barr virus and a host of rhinoviruses—demonstrating that dust can capture both symptomatic and asymptomatic shedding. The high‑throughput nature of the method dramatically reduces labor and time compared with traditional swab or air sampling, providing near‑real‑time insights that can inform targeted cleaning, ventilation upgrades, or temporary occupancy restrictions before outbreaks amplify.

Looking ahead, dust‑based surveillance could become a staple in public‑health toolkits, especially for high‑risk settings such as hospitals, military barracks, and daycare centers. Its low cost, ease of deployment, and ability to reflect demographic patterns—like higher child‑associated virus prevalence—make it attractive for resource‑constrained municipalities. Future work will focus on automating the sampling pipeline, validating viral viability, and integrating data streams with existing wastewater dashboards, ultimately delivering a more granular, layered defense against emerging infectious diseases.